PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-May-2023 Pennine Acute Hospitals NHS Trust embraces new IBM FlashSystem technologies from Covenco to deliver life-saving care round-the-clock Covenco / The Pennine Acute Hospitals NHS Trust
23-May-2023 Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform Tiziana Life Sciences
23-May-2023 UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials Veeva Systems
23-May-2023 PRODUCTLIFE GROUP ACQUIRES CILATUS AND EXPANDS EXPERTISE ON COMPLEX PRODUCTS DEVELOPMENT ProductLife Group (PLG)
23-May-2023 PharmaCord Announces Promotion of Denise Von Dohren to Senior Vice President, Patient Services Newswire
23-May-2023 Former Pyxant Labs and ImaBiotech Announce New Unified Brand as Aliri Newswire
23-May-2023 AlzeCure is granted European patent for NeuroRestore ACD856 AlzeCure
23-May-2023 PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases PharmEnable
23-May-2023 AI based software for crystallization studies Technobis Crystallization Systems
23-May-2023 Vicore obtains significant new patent protection for C21 in the US Vicore Pharma Holding AB
23-May-2023 Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform Scarlet Therapeutics
23-May-2023 Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology Valo Therapeutics
23-May-2023 New SmiLe company Suturion plans to launch its surgical sewing machine this year Suturion
23-May-2023 AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis AnaMar
23-May-2023 Qlucore's software for cancer diagnostics on its way to obtaining CE certification Qlucore
23-May-2023 FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients XBiotech
23-May-2023 YARAL PHARMA PARTNERS WITH EVERSANA TO SUPPORT THE COMMERCIALIZATION OF ITS EXPANDING GENERICS PORTFOLIO EVERSANA
23-May-2023 Orgenesis Academy graduates first class of cell and gene therapy experts from theraCell Laboratories-backed master’s program Orgenesis
23-May-2023 Molecular glues to tackle ‘undruggable’ disease targets Francis Crick Institute
23-May-2023 PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases PharmEnable